A
Alan D. Palkowitz
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
Jun 23, 2026
Ep. 8, Translational Research and Industry Partnerships
6:15
6:27
6:54

Vince WongHOST
Let's talk about what is the IBRI and kind of a little bit about its genesis story and how it's evolved over time.

Alan PalkowitzGUEST
It was a vision between corporate, government, philanthropy, university leadership that really saw the potential for an independent research institute that would sit in between the very strong academic structure that we have in the state, but also the very powerful and strong research – industry, you know, presence that we have through, you know, Roche and Lilly and Elanco and so on and so on.

Alan PalkowitzGUEST
And so, you know, the early days of the IBRI, I think it was with the leadership that was in place was really trying to find its place in its footing.